Biotech Investors & VC Firms in North America
1370 firms in this list, with a median first check of $500K. 289 of them lead rounds. Generated from verified public data and updated continuously.
Y Combinator
San FranciscoPre-Seed–Series A$500K
19 people
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
109 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
56 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
57 people
F-Prime Capital Partners
CambridgePre-Seed–Late Stage$3M – $10M
104 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
43 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
117 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
48 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
117 people
Felicis Ventures
San FranciscoPre-Seed–Series B$500K – $15M
65 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
27 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
64 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
57 people
Canaan Partners
StamfordPre-Seed–Series A$500K – $20M
34 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
69 people
Elevate Ventures
IndianapolisPre-Seed–Growth$20K – $2M
28 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
49 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
67 people
8VC
AustinPre-Seed–Late Stage$100K – $50M
48 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
38 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
54 people
Maryland TEDCO
Upper MarlboroPre-Seed–Seed$500K – $1.5M
77 people
Lux Capital
New YorkPre-Seed–Growth$100K – $100M
47 people
TEDCO
ColumbiaPre-Seed–Series B
74 people
Frequently asked questions
- Who are the top biotech investors & vc firms in north america?
- Top biotech investors & vc firms in north america include Y Combinator, Andreessen Horowitz, Bessemer Venture Partners, Khosla Ventures, F-Prime Capital Partners, Sequoia Capital, OrbiMed, Norwest Venture Partners — 1370 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in north america?
- The median first check among the 1370 biotech investors & vc firms in north america tracked here is $500K.
- How many biotech investors & vc firms in north america lead rounds?
- 289 of the 1370 biotech investors & vc firms in north america tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14037)Investors & VC Firms in United States (13183)Investors & VC Firms in Europe (5556)Crypto & Web3 Investors & VC Firms (4817)Investors & VC Firms in Global (4130)SaaS Investors & VC Firms (3837)AI & Machine Learning Investors & VC Firms (3738)Fintech Investors & VC Firms (3702)Investors & VC Firms in Asia-Pacific (3565)Healthtech Investors & VC Firms (3383)
Data sourced from public filings and firms' own websites — see our methodology.




























.jpeg)









.png)














%20copy.jpg)



































